Patents by Inventor Paulo LaColla

Paulo LaColla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8343937
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: January 1, 2013
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 8299038
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: July 16, 2009
    Date of Patent: October 30, 2012
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Publication number: 20090280086
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: July 16, 2009
    Publication date: November 12, 2009
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7608597
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: October 27, 2009
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi Di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Publication number: 20070293668
    Abstract: The invention as disclosed herein is a method and composition for the treatment of HIV in humans and other host animals, that includes the administration of an effective HIV treatment amount of a phenylindole as described herein or a pharmaceutically acceptable salt or prodrug thereof, optionally in a pharmaceutically acceptable carrier. The compounds of this invention either possess antiviral (i.e., anti-HIV) activity, or are metabolized to a compound that exhibits such activity.
    Type: Application
    Filed: July 20, 2007
    Publication date: December 20, 2007
    Inventors: Paulo LaColla, Marino Artico, Jean-Pierre Sommadossi
  • Publication number: 20070037773
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: September 25, 2006
    Publication date: February 15, 2007
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7169766
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: January 30, 2007
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7163929
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: January 16, 2007
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi Di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7157441
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: January 2, 2007
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi Di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7148206
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: December 12, 2006
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi Di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7105493
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: September 12, 2006
    Assignees: Idenix Pharmaceuticals, Inc., Universita Degli Studi di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 7101861
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: September 5, 2006
    Assignees: Indenix Pharmaceuticals, Inc., Universita Degli Studi Di Cagliari
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Publication number: 20060166865
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: June 20, 2003
    Publication date: July 27, 2006
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 6914054
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: May 23, 2001
    Date of Patent: July 5, 2005
    Assignee: Idenix Pharmaceuticals, Inc.
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Publication number: 20050137161
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: June 20, 2003
    Publication date: June 23, 2005
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Publication number: 20050124532
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1?, 2? or 3?-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: June 20, 2003
    Publication date: June 9, 2005
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Patent number: 6812219
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Grant
    Filed: May 23, 2001
    Date of Patent: November 2, 2004
    Assignee: Idenix Pharmaceuticals, Inc.
    Inventors: Paulo LaColla, Jean-Pierre Sommadossi
  • Publication number: 20040180888
    Abstract: The invention as disclosed herein is a method and composition for the treatment of HIV in humans and other host animals, that includes the administration of an effective HIV treatment amount of a phenylindole as described herein or a pharmaceutically acceptable salt or prodrug thereof, optionally in a pharmaceutically acceptable carrier. The compounds of this invention either possess antiviral (i.e., anti-HIV) activity, or are metabolized to a compound that exhibits such activity.
    Type: Application
    Filed: March 22, 2004
    Publication date: September 16, 2004
    Applicant: IDENIX PHARMACEUTICALS INC.
    Inventors: Paulo LaColla, Marino Artico, Jean-Pierre Sommadossi
  • Publication number: 20040101535
    Abstract: A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: June 20, 2003
    Publication date: May 27, 2004
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla
  • Publication number: 20040102414
    Abstract: A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
    Type: Application
    Filed: June 20, 2003
    Publication date: May 27, 2004
    Inventors: Jean-Pierre Sommadossi, Paulo LaColla